Targeting SHMT2 genetically and pharmacologically inhibits nasopharyngeal carcinoma progression via disruption of the SHMT2-SAM-m6A regulatory circuit and TNF/NF-κB signaling
Publication date: Available online 18 November 2026 Source: European Journal of Pharmacology Author(s): Qiguang Li, Jie Liu, Chong Zeng, Zhuoxian Rong, Qiaoli Lv, Ting Liang
Targeting SHMT2 genetically and pharmacologically inhibits nasopharyngeal carcinoma progression via disruption of the SHMT2-SAM-m6A regulatory circuit and TNF/NF-κB signaling. // Biophysical Reports. – URL: https://www.sciencedirect.com/science/article/pii/S001429992601068X?dgcid=rss_sd_all
Targeting SHMT2 genetically and pharmacologically inhibits nasopharyngeal carcinoma progression via disruption of the SHMT2-SAM-m6A regulatory circuit and TNF/NF-κB signaling. Biophysical Reports. https://www.sciencedirect.com/science/article/pii/S001429992601068X?dgcid=rss_sd_all
“Targeting SHMT2 genetically and pharmacologically inhibits nasopharyngeal carcinoma progression via disruption of the SHMT2-SAM-m6A regulatory circuit and TNF/NF-κB signaling.” Biophysical Reports.
@article{article11217,
title = {Targeting SHMT2 genetically and pharmacologically inhibits nasopharyngeal carcinoma progression via disruption of the SHMT2-SAM-m6A regulatory circuit and TNF/NF-κB signaling},
journal = {Biophysical Reports},
url = {https://www.sciencedirect.com/science/article/pii/S001429992601068X?dgcid=rss_sd_all}
}
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Jun-Jie Zhang, Danni Colledge, Andrea Jurado, Ning Sun, Hu Zhang, Kathy Jackson, Vitina Sozzi, Xin Li, Nicholas S. Eyre, Michael R. Beard, Radhakrishnan...
Publication date: December 2026 Source: Antiviral Research, Volume 256 Author(s): Sneha Singh, Arijit Vijey Jeyachandran, Maria Daskou, Anne Zaiss, Henry Kolge, Robert E. Wright, Anita Singhal, Anna Bonazzi, Robert Damoiseaux,...